Renno, Waleed M <br/><br/>
(-)-Epigallocatechin-3-gallate (EGCG) attenuates functional deficits and morphological alterations by diminishing apoptotic gene overexpression in skeletal muscles after sciatic nerve crush injury.  [electronic resource] 

 -  Naunyn-Schmiedeberg's archives of pharmacology  Aug 2012 
 - 807-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1912 
<br/><br/><label>Standard No.: </label>10.1007/s00210-012-0758-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--biosynthesis<br/>Behavior, Animal--drug effects<br/>Catechin--analogs & derivatives<br/>Desmin--metabolism<br/>Foot--physiology<br/>Hot Temperature<br/>Hyperalgesia--drug therapy<br/>Immunohistochemistry<br/>Male<br/>Muscle, Skeletal--metabolism<br/>Nerve Crush<br/>Neuroprotective Agents--pharmacology<br/>Pain Measurement--drug effects<br/>Posture--physiology<br/>RNA--biosynthesis<br/>Rats<br/>Rats, Wistar<br/>Reaction Time--drug effects<br/>Real-Time Polymerase Chain Reaction<br/>Recovery of Function<br/>Sciatic Neuropathy--drug therapy<br/>Signal Transduction--drug effects<br/>Toes--physiology